A detailed history of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds 633,090 shares of VRDN stock, worth $12.5 Million. This represents 2.0% of its overall portfolio holdings.

Number of Shares
633,090
Holding current value
$12.5 Million
% of portfolio
2.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$12.16 - $23.33 $7.7 Million - $14.8 Million
633,090 New
633,090 $14.4 Billion

Others Institutions Holding VRDN

About Viridian Therapeutics, Inc.\DE


  • Ticker VRDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,888,900
  • Market Cap $789M
  • Description
  • Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...
More about VRDN
Track This Portfolio

Track Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Portfolio

Follow Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A., based on Form 13F filings with the SEC.

News

Stay updated on Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. with notifications on news.